home / stock / axsm / axsm quote
Last: | $78.50 |
---|---|
Change Percent: | -0.47% |
Open: | $76.75 |
Close: | $78.50 |
High: | $79.1 |
Low: | $76.2066 |
Volume: | 1,023,349 |
Last Trade Date Time: | 06/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$78.5 | $76.75 | $78.5 | $79.1 | $76.2066 | 1,023,349 | 06-24-2024 |
$76.39 | $75.31 | $76.39 | $76.685 | $74 | 917,680 | 06-21-2024 |
$75.18 | $75.44 | $75.18 | $76.21 | $72.02 | 699,757 | 06-20-2024 |
$76.02 | $75.34 | $76.02 | $76.89 | $75.34 | 572,592 | 06-19-2024 |
$76.02 | $75.34 | $76.02 | $76.89 | $75.34 | 572,592 | 06-18-2024 |
$76 | $73.19 | $76 | $77.275 | $73.0213 | 1,172,504 | 06-17-2024 |
$73.63 | $72.11 | $73.63 | $74.29 | $71.15 | 494,003 | 06-14-2024 |
$72.51 | $71.34 | $72.51 | $72.66 | $70.52 | 708,918 | 06-13-2024 |
$71.55 | $72.78 | $71.55 | $72.89 | $70.11 | 736,806 | 06-12-2024 |
$71.07 | $66.9 | $71.07 | $71.36 | $64.11 | 3,361,767 | 06-11-2024 |
$71.8 | $73.27 | $71.8 | $73.9 | $70.85 | 1,031,481 | 06-10-2024 |
$73.9 | $74 | $73.9 | $75.85 | $73.3 | 481,794 | 06-07-2024 |
$74.76 | $74.01 | $74.76 | $75.5 | $73.64 | 332,013 | 06-06-2024 |
$74.09 | $73.08 | $74.09 | $74.68 | $72.02 | 652,133 | 06-05-2024 |
$72.24 | $74.75 | $72.24 | $75.135 | $71.46 | 837,619 | 06-04-2024 |
$74.74 | $74.33 | $74.74 | $75.77 | $73.15 | 718,547 | 06-03-2024 |
$73.43 | $74.58 | $73.43 | $75.85 | $72.69 | 668,111 | 05-31-2024 |
$74.21 | $76 | $74.21 | $76.38 | $73.85 | 629,418 | 05-30-2024 |
$75.21 | $75.9 | $75.21 | $75.95 | $73.11 | 636,396 | 05-29-2024 |
$76.76 | $75.88 | $76.76 | $76.97 | $74.64 | 481,678 | 05-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Axsome Therapeutics Inc. Company Name:
AXSM Stock Symbol:
NASDAQ Market:
Axsome Therapeutics Inc. Website:
2024-06-11 16:30:03 ET Guggenheim analyst issues BUY recommendation for AXSM on June 11, 2024 03:28PM ET. The previous analyst recommendation was Buy. AXSM was trading at $71.07 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...
NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced that it has entered into a settlement agreement with Un...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, announced today it is joining the migraine advocacy community to raise awarenes...